Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

Mukta Arora, MD, Madan Jagasia, MBBS, MS, MMHC, Antonio Di Stasi, MD, Michael L Meyers, MD PhD, Christine Quaranto, Aaron Schmitt, Serap Sankoh, Mohammad Issam Abu Zaid, MBBS, Geoff R Hill, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Peter Ordentlich, PhD, Stephanie J. Lee, MDMPH

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-141553

Published: 2020

Journal Articles

Predictors and Outcomes of Flares in Chronic Graft-Versus-Host Disease

Grigori Okoev, MD PhD, Daniel J. Weisdorf, MD, John E Wagner, MD, Bruce R. Blazar, MD, Margaret L. MacMillan, MD, Todd E. DeFor, MS, Aleksandr Lazaryan, MDPhDMPH, Najla H El Jurdi, MD, Shernan G Holtan, MD, Claudio G. Brunstein, MD PhD, Brian C. Betts, MD, Takuto Takahashi, MD, Veronika Bachanova, MD PhD, Erica D. Warlick, MD, Armin Rashidi, MD PhD, Mukta Arora, MD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-136479

Published: 2020

Journal Articles

Coronary Heart Disease Risk in Blood or Marrow Transplant Survivors

Radhika Gangaraju, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Daniel J. Weisdorf, MD, Stephen J. Forman, MD, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MDMPH

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-137731

Published: 2020

Journal Articles

Severe/Life-Threatening/Fatal Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) in Childhood - a Report from the BMT Survivor Study (BMTSS)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, MPH, Lindsey Hageman, MPH, Kevin D. Battles, BS, Liton F. Francisco, BS, Michelle Kung, MA, Frederick Goldman, MDMS, Joseph Rosenthal, MD MS, Stephen J. Forman, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MDMPH

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-133895

Published: 2020

Journal Articles

Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-137221

Published: 2020

Journal Articles

High Incidence of Venous Thromboembolism in Patients with Chronic Graft-Versus-Host Disease

Blood (2020) 136 (Supplement 1): 44–46.

https://doi.org/10.1182/blood-2020-136337

Published: 2020

Journal Articles

Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS)

Caitlin W Elgarten, MD MSc, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Richard Aplenc, MD PhD, Michael T. Hemmer, MS, Mukta Arora, MD, Stephen R. Spellman, MS, Tao Wang, PhD, Madan Jagasia, MBBS, MS, MMHC, Margaret L. MacMillan, MD, Joseph Pidala, MD, Brian T. Fisher, DO, MSCE, Matt Hall, PhD

Blood (2019) 134 (Supplement_1): 599.

https://doi.org/10.1182/blood-2019-130466

Published: 2019

Journal Articles

Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors - a BMT Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, MS, Jessica Wu, MPH, Lindsey Hageman, MPH, Emily Ness, MPH, Michelle Kung, MA, Liton F. Francisco, BS, Alysia Bosworth, BA, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Wendy Landier, PhD CRNP, Merve - Pamukçuoğlu, MD, Saro H. Armenian, DO, MPH, Lennie Wong, PhD, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 699.

https://doi.org/10.1182/blood-2019-123344

Published: 2019

Journal Articles

Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) - a Report from the BMT Survivor Study (BMTSS)

Saro H. Armenian, DO, MPH, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Emily Ness, MPH, Mariel Parman, MPH, Wendy Landier, PhD CRNP, Alysia Bosworth, BA, Lennie Wong, PhD, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 707.

https://doi.org/10.1182/blood-2019-126248

Published: 2019

Journal Articles

Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)

Radhika Gangaraju, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Wendy Landier, PhD CRNP, Liton F. Francisco, BS, Andrew McDonald, Donna Murdaugh, PhD, Michelle Kung, MA, Emily Ness, MPH, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Lennie Wong, PhD, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 3298.

https://doi.org/10.1182/blood-2019-124564

Published: 2019

Journal Articles

Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)

Grigori Okoev, MD PhD, Daniel J. Weisdorf, MD, John E. Wagner, MD, Bruce R. Blazar, MD, Margaret L. MacMillan, MD, Todd E. DeFor, MS, Aleksandr Lazaryan, MDPhDMPH, Najla H El Jurdi, MD, Shernan Holtan, MD, Claudio G Brunstein, MD PhD, Brian C. Betts, MD, Takuto Takahashi, MD, Veronika Bachanova, MD PhD, Erica D. Warlick, MD, Armin Rashidi, MD PhD, Mukta Arora, MD

Blood (2019) 134 (Supplement_1): 2009.

https://doi.org/10.1182/blood-2019-123421

Published: 2019

Journal Articles

Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study

Rebecca L. Olin, MD, Caitrin Fretham, Marcelo C. Pasquini, MD, Mukta Arora, MD, Vijaya R. Bhatt, MD, Benjamin Derman, MDBA, Sergio A Giralt, MD, Li-Wen Huang, MD, Thuy T. Koll, MD, Sang Mee Lee, PhD, Richard J Lin, MD PhD, Linda Pang, MD, Uday Popat, MD, Daniel J. Weisdorf, MD, Andrew S. Artz, MD

Blood (2019) 134 (Supplement_1): 4606.

https://doi.org/10.1182/blood-2019-123598

Published: 2019

Journal Articles

Venous Thromboembolism in Blood or Marrow Transplant (BMT) Survivors: A Report from BMT Survivor Study (BMTSS)

Radhika Gangaraju, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Emily Ness, MPH, Mariel Parman, MPH, Daniel J. Weisdorf, MD, Stephen J Forman, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 823.

https://doi.org/10.1182/blood-2018-99-111179

Published: 2018

Journal Articles

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Blood (2018) 132 (Supplement 1): 71.

https://doi.org/10.1182/blood-2018-99-113564

Published: 2018

Journal Articles

Chronic Severe Pain and Use of Prescription Pain Medications in Older Survivors of Hematologic Malignancies (HM) Several Years after Treatment with Blood or Marrow Transplantation (BMT): A Report from BMTSS

Naveed Farrukh, Lindsey Hageman, MPH, Yanjun Chen, MS, Jessica Wu, MPH, Emily Ness, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Wendy Landier, PhD CRNP, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Grant R Williams, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 715.

https://doi.org/10.1182/blood-2018-99-111500

Published: 2018

Journal Articles

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Ayman Saad, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Lawrence S. Lamb, Jr., PhD, Shahrukh K. Hashmi, MD MPH

Blood (2018) 132 (Supplement 1): 3410.

https://doi.org/10.1182/blood-2018-99-113513

Published: 2018

Journal Articles

5 Year Health Care Burden after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Impact of Graft Source

Jesus Garcia Garcia, BS, Sonya Grillo, Qing Cao, MS, Claudio G Brunstein, MD PhD, Mukta Arora, MD, Margaret L. MacMillan, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Shernan G. Holtan, MD

Blood (2018) 132 (Supplement 1): 367.

https://doi.org/10.1182/blood-2018-99-113201

Published: 2018

Journal Articles

Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) — Results of the BMT Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Emily Ness, MPH, Mariel Parman, MPH, Daniel J. Weisdorf, MD, Stephen J Forman, Saro H. Armenian, DO, MPH, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 2127.

https://doi.org/10.1182/blood-2018-99-112702

Published: 2018

Journal Articles

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Michelle Kung, MA, Emily Ness, MPH, Kevin D. Battles, BS, Jeanette Falck Winther, MD DMSc, Joseph Rosenthal, MD MS, Ravi Bhatia, MD, Donna Salzman, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 337.

https://doi.org/10.1182/blood.V130.Suppl_1.337.337

Published: 2017

Journal Articles

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Emily Ness, MPH, Mariel Parman, MPH, Michelle Kung, MA, Alysia Bosworth, BA, Manju Nayar, Ravi Bhatia, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 336.

https://doi.org/10.1182/blood.V130.Suppl_1.336.336

Published: 2017

NARROW

Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

Predictors and Outcomes of Flares in Chronic Graft-Versus-Host Disease

Coronary Heart Disease Risk in Blood or Marrow Transplant Survivors

Severe/Life-Threatening/Fatal Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) in Childhood - a Report from the BMT Survivor Study (BMTSS)

Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens

High Incidence of Venous Thromboembolism in Patients with Chronic Graft-Versus-Host Disease

Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS)

Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors - a BMT Survivor Study (BMTSS)

Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) - a Report from the BMT Survivor Study (BMTSS)

Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)

Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)

Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study

Venous Thromboembolism in Blood or Marrow Transplant (BMT) Survivors: A Report from BMT Survivor Study (BMTSS)

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Chronic Severe Pain and Use of Prescription Pain Medications in Older Survivors of Hematologic Malignancies (HM) Several Years after Treatment with Blood or Marrow Transplantation (BMT): A Report from BMTSS

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

5 Year Health Care Burden after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Impact of Graft Source

Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) — Results of the BMT Survivor Study (BMTSS)

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only